Recommended Dosage of Triamcinolone Acetonide for Rash in an 18-Year-Old
For an 18-year-old with a rash, triamcinolone acetonide can be administered at 10 mg/mL concentration, which may be diluted with sterile normal saline to 5 or 3.3 mg/mL depending on the type and severity of the rash. 1
Dosing Guidelines Based on Rash Type
For Inflammatory/Nodular Lesions:
- Triamcinolone acetonide 10 mg/mL for inflammatory follicular lesions 1
- May be diluted to 5 or 3.3 mg/mL with sterile normal saline for smaller or less severe lesions 1
- For adults, doses up to 10 mg for smaller areas and up to 40 mg for larger areas are typically sufficient 2
For Hypertrophic Scars or Keloids:
- Higher concentration (triamcinolone acetonide 40 mg/mL) may be used 1
Administration Technique
- Inject directly into the lesion using strict aseptic technique 2
- Ensure proper injection technique to avoid blood vessels 2
- For multiple lesions, single injections into several areas up to a total of 80 mg can be administered 2
Contraindications
- Do not inject at sites of active infections (impetigo, herpes) 1
- Avoid in patients with hypersensitivity to triamcinolone 1
- Use caution in patients with:
Expected Response
- Most inflammatory lesions flatten within 48 to 72 hours 1
- Efficacious for occasional or particularly stubborn lesions 1
- Not an effective strategy for patients with multiple widespread lesions 1
Potential Adverse Effects
- Local overdose can result in skin atrophy, pigmentary changes, and telangiectasias 1
- Other potential side effects include:
Alternative Treatments to Consider
- For widespread rashes, topical corticosteroids may be more appropriate:
- For pruritic rashes, oral antihistamines may be added (cetirizine/loratadine 10 mg daily or hydroxyzine 10-25 mg QID) 1
Clinical Pearls
- Shake the vial before use to ensure uniform suspension 2
- Inspect for clumping or granular appearance before withdrawal 2
- Inject without delay after withdrawal to prevent settling in the syringe 2
- Consider topical treatments for widespread rashes rather than multiple injections 3
- Percutaneous absorption of topical triamcinolone is generally minimal in patients with intact skin 4